A Platelet-Inspired Paradigm for Nanomedicine Targeted to Multiple Diseases

• Deutsch VR , TomerA. Megakaryocyte development and platelet production. Br. J. Haematol.134(5), 453–466 (2006).
   PubMed Web of Science ®Google Scholar
• Platelets. Michelson AD (Ed.). Academic Press, CA, USA (2012).
   Google Scholar
• Ruggeri ZM . Platelets in atherothrombosis. Nat. Med.8(11), 1227–1234 (2002).
   PubMed Web of Science ®Google Scholar
• Smyth SS , McEverRP, WeyrichASet al. Platelet functions beyond hemostasis. J. Thromb. Haemost. 7(11), 1759–1766 (2009).
   PubMed Web of Science ®Google Scholar
• Ware J , SuvaLJ. Platelets to hemostasis and beyond. Blood117(14), 3703–3704 (2011).
   PubMed Web of Science ®Google Scholar
• Italiano JE , BergmeierW, TiwariSet al. Mechanisms and implications of platelet discoid shape. Blood 101(12), 4789–4796 (2003).
   PubMed Web of Science ®Google Scholar
• Radmacher M , FritzM, KacherCM, ClevelandJP, HansmaPK. Measuring the viscoelastic properties of human platelets with the atomic force microscope. Biophys. J.70(1), 556–567 (1996).
   PubMed Web of Science ®Google Scholar
• Tokarev AA , ButylinAA, ErmakovaEA, ShnolEE, PanasenkoGP, AtaullakhanovFI. Finite platelet size could be responsible for platelet margination effect. Biophys. J.101(8), 1835–1843 (2011).
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM . Platelet adhesion under flow. Microcirculation16(1), 58–83 (2009).
   PubMed Web of Science ®Google Scholar
• Kuwahara M , SugimotoM, TsujiSet al. Platelet shape changes and adhesion under high shear flow. Arterioscler. Thromb. Vasc. Biol. 22(2), 329–334 (2002).
   PubMed Web of Science ®Google Scholar
• Mackman N . Triggers, targets and treatments for thrombosis. Nature451(7181), 914–918 (2008).
   PubMed Web of Science ®Google Scholar
• D‘Souza SE , GinsbergMH, MatsuedaGR, PlowEF. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature350(6313), 66–68 (1991).
   PubMed Web of Science ®Google Scholar
• Monroe D , HoffmanM, RobertsH. Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol.22, 1381–1389 (2002).
   PubMed Web of Science ®Google Scholar
• Stassen JM , ArnoutJ, DeckmynH. The hemostatic system. Curr. Med. Chem.11(17), 2245–2260 (2004).
   PubMed Web of Science ®Google Scholar
• Modery-Pawlowski CL , TianLL, PanV, McCraeKR, MitragotriS, Sen Gupta A. Approaches to synthetic platelet analogs. Biomaterials34(2), 526–541 (2012).
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM , MendolicchioGL. Adhesion mechanisms in platelet function. Circ. Res.100(12), 1673–1685 (2007).
   PubMed Web of Science ®Google Scholar
• Okamura Y , HandaM, SuzukiH, IkedaY, TakeokaS. New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions. J. Artif. Organs9(4), 251–258 (2006).
   PubMedGoogle Scholar
• Nishiya T , KainohM, MurataM, HandaM, IkedaY. Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor–ligand interactions. Blood100(1), 136–142 (2002).
   PubMed Web of Science ®Google Scholar
• Ravikumar M , ModeryCL, WongTL, Sen Gupta A. Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes. Bioconjug. Chem.23(6), 1266–1275 (2012).
   PubMed Web of Science ®Google Scholar
• Ravikumar M , ModeryCL, WongTL, Sen Gupta A. Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro. Biomacromolecules.13(5), 1495–1502 (2012).
   PubMed Web of Science ®Google Scholar
• Modery-Pawlowski CL , TianLL, RavikumarM, WongTL, Sen Gupta A. In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct. Biomaterials34(12), 3031–3041 (2013).
   PubMed Web of Science ®Google Scholar
• Decuzzi P , LeeS, BhushanB, FerrariM. A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng.33(2), 179–190 (2005).
   PubMed Web of Science ®Google Scholar
• Tao L , HuW, LiuY, HuangG, SumerBD, GaoJ. Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp. Biol. Med. (Maywood).236(1), 20–29 (2011).
   PubMed Web of Science ®Google Scholar
• Charoenphol P , MocherlaS, BouisD, NamdeeK, PinskyDJ, Eniola-AdefesoO. Targeting therapeutics to the vascular wall in atherosclerosis – carrier size matters. Atherosclerosis217(2), 364–370 (2011).
   PubMed Web of Science ®Google Scholar
• Nesbitt WS , WesteinE, Tovar-LopezFJet al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat. Med. 15(6), 665–673 (2009).
   PubMed Web of Science ®Google Scholar
• Doshi N , OrjeJN, MolinsB, SmithJW, MitragortiS, RuggeriZM. Platelet mimetic particles for targeting thrombi in flowing blood. Adv. Mater.24(28), 3864–3869 (2012).
   PubMed Web of Science ®Google Scholar
• Chiu GNC , BallyMB, MayerLD. Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis. Biochim. Biophys. Acta.1613(1–2), 115–121 (2003).
   PubMed Web of Science ®Google Scholar
• Okamura Y , KatsunoS, SuzukiHet al. Release abilities of adenosine diphosphate from phospholipid vesicles with different membrane properties and their hemostatic effects as a platelet substitute. J. Control. Release 148(3), 373–379 (2010).
   PubMed Web of Science ®Google Scholar
• Kona S , DongJF, LiuY, TanJ, NguyenKT. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int. J. Pharm.423(2), 516–524 (2012).
   PubMedGoogle Scholar
• Wagner DD , BurgerPC. Platelets in inflammation and thrombosis. Arterioscler. Thromb. Vasc. Biol.23(12), 2131–2137 (2003).
   PubMed Web of Science ®Google Scholar
• Meijden PEJ , HeemskerkJWM, HamulyákK, CateH. Classification of venous thromboembolism (VTE). Platelets in venous thrombosis. J. Thromb. Haemost.3(11), 2575–2577 (2005).
   PubMedGoogle Scholar
• Le Breton H , PlowEF, TopolEJ. Role of platelets in restenosis after percutaneous coronary revascularization. J. Am. Coll. Cardiol.28(7), 1643–1651 (1996).
   PubMed Web of Science ®Google Scholar
• Weyrich AS , PrescottSM, ZimmermanGA. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation106(12), 1433–1435 (2002).
   PubMed Web of Science ®Google Scholar
• Massberg S , BrandK, GrunerSet al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196(7), 887–896 (2002).
   PubMed Web of Science ®Google Scholar
• Merten M , ThiagarajanP. P-selectin in arterial thrombosis. Z. Kardiol.93(11), 855–863 (2004).
   PubMedGoogle Scholar
• Blann AD , NadarSK, LipGY. The adhesion molecule P-selectin and cardiovascular disease. Eur. Heart J.24(24), 2166–2179 (2003).
   PubMed Web of Science ®Google Scholar
• Smolenski A . Novel roles of cAMP/cGMP-dependent signaling in platelets. J. Thromb. Haemost.10(2), 167–176 (2012).
   PubMed Web of Science ®Google Scholar
• Lowe G . Virchow‘s triad revisited: abnormal flow. Pathophysiol. Haemost. Thromb.33(5–6), 455–457 (2003).
   PubMedGoogle Scholar
• Jerjes-Sanchez C . Venous and arterial thrombosis: a continuous spectrum of the same disease? Eur. Heart J.26(1), 3–4 (2005).
   PubMed Web of Science ®Google Scholar
• Totani L , EvangelistaV. Platelet–leukocyte interactions in cardiovascular disease and beyond. Arterioscler. Thromb. Vasc. Biol.30(12), 2357–2361 (2010).
   PubMed Web of Science ®Google Scholar
• Jones CB , SaneDC, HerringtonDM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc. Res.59(4), 812–823 (2003).
   PubMed Web of Science ®Google Scholar
• Santos-Martínez MJ , MedinaC, JuraszP, RadomskiMW. Role of metalloproteinases in platelet function. Thromb. Res.121(4), 535–542 (2008).
   PubMed Web of Science ®Google Scholar
• Demos SM , Alkan-OnyukselH, KaneBJet al.: In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J. Am. Coll. Cardiol.33(3), 867–875 (1999).
   PubMed Web of Science ®Google Scholar
• Klegerman ME , ZouY, McPhersonDD. Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator. J. Liposome Res.18(2), 95–112 (2008).
   PubMed Web of Science ®Google Scholar
• Heeremans JL , PrevostR, BekkersMEet al. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb. Haemost. 73(3), 488–494 (1995).
   PubMed Web of Science ®Google Scholar
• Leach JK , O‘RearEA, PattersonE, MiaoY, JohnsonAE. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. Thromb. Haemost.90(1), 64–70 (2003).
   PubMed Web of Science ®Google Scholar
• Peters D , KastantinM, KotamrajuVRet al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc. Natl Acad. Sci. USA 106(24), 9815–9819 (2009).
   PubMed Web of Science ®Google Scholar
• Yu X , SongSK, ChenJet al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. 44(6), 867–872 (2000).
   PubMed Web of Science ®Google Scholar
• McCarthy JR , WeisslederR. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev.60(11), 1241–1251 (2008).
   PubMed Web of Science ®Google Scholar
• Lanza GM , YuX, WinterPMet al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 106(22), 2842–2847 (2002).
   PubMed Web of Science ®Google Scholar
• Alonso A , Della Martina A, Stroick M et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke38(5), 1508–1514 (2007).
   PubMed Web of Science ®Google Scholar
• Sen Gupta A , HuangG, LestiniBJ, SagnellaS, Kottke-MarchantK, MarchantRE. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thromb. Haemost.93(1), 106–114 (2005).
   PubMed Web of Science ®Google Scholar
• Huang G , ZhouZ, SrinivasanRet al. Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets. Biomaterials 29(11), 1676–1685 (2008).
   PubMed Web of Science ®Google Scholar
• Srinivasan R , MarchantRE, Sen Gupta A. In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes. J. Biomed. Mater. Res. A93(3), 1004–1015.
   PubMedGoogle Scholar
• Modery CL , RavikumarM, WongTL, DzurickyMJ, DurongkaverojN, Sen Gupta A. Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery. Biomaterials32(35), 9504–9514 (2011).
   PubMed Web of Science ®Google Scholar
• Kawata H , UesugiY, SoedaTet al. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. J. Am. Coll. Cardiol. 60(24), 2550–2557 (2012).
   PubMed Web of Science ®Google Scholar
• Chan JM , ZhangL, TongRet al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc. Natl Acad. Sci. USA 107(5), 2213–2218 (2010).
   PubMed Web of Science ®Google Scholar
• Korin N , KanapathipillaiM, MatthewsBDet al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 337(6095), 738–742 (2012).
   PubMed Web of Science ®Google Scholar
• Sen Gupta A . Nanomedicine approaches in vascular disease: a review. Nanomedicine7(6), 763–779 (2011).
   PubMed Web of Science ®Google Scholar
• Klinger MHF , JelkmannW. Role of blood platelets in infection and inflammation. J. Interferon Cytokine Res.22(9), 913–922 (2002).
   PubMed Web of Science ®Google Scholar
• Petersen F , BockL, FladHD, BrandtE. Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8. Blood94(12), 4020–4028 (1999).
   PubMed Web of Science ®Google Scholar
• Brindley LL , SweetJM, GoetzlEJ. Stimulation of histamine release from human basophils by human platelet factor 4. J. Clin. Invest.72(4), 1218–1223 (1983).
   PubMed Web of Science ®Google Scholar
• Baggiolini M , DewaldB, MoserB. Interleukin-8 and related chemotactic cytokines – CXC and CC chemokines. Adv. Immunol.55, 97–179 (1994).
   PubMed Web of Science ®Google Scholar
• Piccardoni P , EvangelistaV, PiccoliA, de Gaetano G, Walz A, Cerletti C. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes. Thromb. Haemost.76(5), 780–785 (1996).
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P , WeberKS, HuoYet al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103(13), 1772–1777 (2001).
   PubMed Web of Science ®Google Scholar
• Gawaz M , BrandK, DickfeldTet al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 148(1), 75–85 (2000).
   PubMed Web of Science ®Google Scholar
• Brandt E , LudwigA, PetersenF, FladHD. Platelet-derived CXC chemokines: old players in new games. Immunol. Rev.177, 204–216 (2000).
   PubMed Web of Science ®Google Scholar
• Wahl SM , HuntDA, WakefieldLMet al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl Acad. Sci. USA 84(16), 5788–5792 (1987).
   PubMed Web of Science ®Google Scholar
• Soma Y , TakeharaK, IshibashiY. Alteration of the chemotactic response of human skin fibroblasts to PDGF by growth factors. Exp. Cell Res.212(2), 274–277 (1994).
   PubMed Web of Science ®Google Scholar
• Furman MI , BenoitSE, BarnardMRet al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J. Am. Coll. Cardiol. 31(2), 352–358 (1998).
   PubMed Web of Science ®Google Scholar
• Blanks JE , MollT, EytnerR, VestweberD. Stimulation of P-selectin glycoprotein ligand-1 on mouse neutrophils activates beta 2-integrin mediated cell attachment to ICAM-1. Eur. J. Immunol.28(2), 433–443 (1998).
   PubMed Web of Science ®Google Scholar
• Kuijper PH , Gallardo Tores HI, Lammers JW, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions. Thromb. Haemost.80(3), 443–448 (1998).
   PubMed Web of Science ®Google Scholar
• van Kooten C , BanchereauJ. CD40–CD40 ligand. J. Leukoc. Biol.67(1), 2–17 (2000).
   PubMed Web of Science ®Google Scholar
• Barnes PJ . New aspects of asthma. J. Intern. Med.231(5), 453–461 (1992).
   PubMed Web of Science ®Google Scholar
• Endresen GK . Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis. Rheumatol. Int.9(1), 19–24 (1989).
   PubMed Web of Science ®Google Scholar
• Bunescu A , SeidemanP, LenkeiR, LevinK, EgbergN. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J. Rheumatol.31(12), 2347–2355 (2004).
   PubMed Web of Science ®Google Scholar
• Collins CE , CahillMR, NewlandAC, RamptonDS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology106(4), 840–845 (1994).
   PubMed Web of Science ®Google Scholar
• Kirsten A , WatzH, KretschmarGet al. Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – a double blind, randomized, placebo-controlled, cross-over clinical trial. Pulm. Pharmacol. Ther. 24(5), 555–558 (2011).
   PubMed Web of Science ®Google Scholar
• Li N , HuH, HjemdahlP. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb. Res.111(3), 165–170 (2003).
   PubMed Web of Science ®Google Scholar
• Boilard E , NigrovicPA, LarabeeKet al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327(5965), 580–583 (2010).
   PubMed Web of Science ®Google Scholar
• Kaila N , JanzK, DeBernardoSet al. Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists. J. Med. Chem. 50(1), 21–39 (2007).
   PubMed Web of Science ®Google Scholar
• Sumariwalla PF , MalfaitAM, FeldmannM. P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor. Clin. Exp. Immunol.136(1), 67–75 (2004).
   PubMed Web of Science ®Google Scholar
• Richards PJ , WilliamsAS, GoodfellowRM, WilliamsBD. Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. Rheumatology (Oxford)38(9), 818–825 (1999).
   PubMed Web of Science ®Google Scholar
• Metselaar JM , WaubenMHM, Wagenaar-HilbersJPA, BoermanOC, StormG. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum.48(7), 2059–2066 (2003).
   PubMed Web of Science ®Google Scholar
• Lamprecht A , YamamotoH, TakeuchiH, KawashimaY. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. J. Pharmacol. Exp. Ther.315(1), 196–202 (2005).
   PubMed Web of Science ®Google Scholar
• Jubeh TT , BarenholzY, RubinsteinA. Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm. Res.21(3), 447–453 (2004).
   PubMed Web of Science ®Google Scholar
• Koning GA , SchiffelersRM, WaubenMHMet al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 54(4), 1198–1208 (2006).
   PubMed Web of Science ®Google Scholar
• Minaguchi J , OohashiT, InagawaK, OhtsukaA, NinomiyaY. Transvascular accumulation of Sialyl Lewis X conjugated liposome in inflamed joints of collagen antibody-induced arthritic (CAIA) mice. Arch. Histol. Cytol.71(3), 195–203 (2008).
   PubMedGoogle Scholar
• Sakhalkar HS , DalalMK, SalemAKet al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc. Natl Acad. Sci. USA 100(26), 15895–15900 (2003).
   PubMed Web of Science ®Google Scholar
• Baldwin WM , Kuo H-H, Morrell CN. Platelets: versatile modifiers of innate and adaptive immune responses to transplants. Curr. Opin. Organ Transplant.16(1), 41–46 (2011).
   PubMed Web of Science ®Google Scholar
• Koo DD , WelshKI, RoakeJA, MorrisPJ, FuggleSV. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am. J. Pathol.153(2), 557–566 (1998).
   PubMed Web of Science ®Google Scholar
• Jassem W , KooDDH, CerundoloL, RelaM, HeatonND, FuggleSV. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation76(11), 1599–1603 (2003).
   PubMed Web of Science ®Google Scholar
• Meehan SM , LimsrichamrernS, ManaligodJRet al. Platelets and capillary injury in acute humoral rejection of renal allografts. Hum. Pathol. 34(6), 533–540 (2003).
   PubMed Web of Science ®Google Scholar
• Singbartl K , ForlowSB, LeyK. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J.15(13), 2337–2344 (2001).
   PubMed Web of Science ®Google Scholar
• Morrell CN , MurataK, SwaimAMet al.: In vivo platelet–endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ. Res.102(7), 777–785 (2008).
   PubMed Web of Science ®Google Scholar
• Swaim AF , FieldDJ, Fox-TalbotK, BaldwinWM, MorrellCN. Platelets contribute to allograft rejection through glutamate receptor signaling. J. Immunol.185(11), 6999–7006 (2010).
   PubMed Web of Science ®Google Scholar
• Nankivell BJ , AlexanderSI. Rejection of the kidney allograft. N. Engl. J. Med.363(15), 1451–1462 (2010).
   PubMed Web of Science ®Google Scholar
• Hattori R , HamiltonKK, McEverRP, SimsPJ. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem.264(15), 9053–9060 (1989).
   PubMed Web of Science ®Google Scholar
• Yamakuchi M , Kirkiles-SmithNC, FerlitoMet al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc. Natl Acad. Sci. USA 104(4), 1301–1306 (2007).
   PubMed Web of Science ®Google Scholar
• Morrell CN , SunH, SwaimAM, BaldwinWM. Platelets an inflammatory force in transplantation. Am. J. Transplant.7(11), 2447–2454 (2007).
   PubMed Web of Science ®Google Scholar
• Kuo HH , MorrellCN, BaldwinWM. Alloantibody induced platelet responses in transplants: potent mediators in small packages. Hum. Immunol.73(12), 1233–1238 (2012).
   PubMed Web of Science ®Google Scholar
• Xu H , ZhangX, MannonRB, KirkAD. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J. Clin. Invest.116(3), 769–774 (2006).
   PubMed Web of Science ®Google Scholar
• Baganz NL , BlakelyRD. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem. Neurosci.4(1), 48–63 (2013).
   PubMed Web of Science ®Google Scholar
• Dees C , AkhmetshinaA, ZerrPet al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J. Exp. Med. 208(5), 961–972 (2011).
   PubMed Web of Science ®Google Scholar
• Semple JW , ItalianoJE, FreedmanJ. Platelets and the immune continuum. Nat. Rev. Immunol.11(4), 264–274 (2011).
   PubMed Web of Science ®Google Scholar
• Garraud O , ChavarinP, FabrigilP, Hamzeh-CognasseH, CongnasseF. Novel functions of therapeutic platelets as “immune cells”. J. Blood Disord. TransfusionS1, 1–6 (2011).
   Google Scholar
• Asgeirsdóttir SA , ZwiersPJ, MorseltHWet al. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am. J. Physiol. Renal Physiol. 294(3), F554–F561 (2008).
   PubMed Web of Science ®Google Scholar
• Baldwin WM , KasperEK, ZacharyAA, WasowskaBA, RodriguezER. Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection. Am. J. Transplant.4(3), 311–318 (2004).
   PubMed Web of Science ®Google Scholar
• Collier BD , AdamsMB, KauffmanHMet al. Accurate diagnosis of renal transplant rejection by indium-111 platelet imaging despite postoperative cyclosporin therapy. Clin. Nucl. Med. 13(8), 606–610 (1988).
   PubMed Web of Science ®Google Scholar
• Pantel K , BrakenhoffRH. Dissecting the metastatic cascade. Nat. Rev. Cancer4(6), 448–456 (2004).
   PubMed Web of Science ®Google Scholar
• Jurasz P , Alonso-EscolanoD, RadomskiMW. Platelet – cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br. J. Pharmacol.143(7), 819–826 (2004).
   PubMed Web of Science ®Google Scholar
• Bambace NM , HolmesCE. The platelet contribution to cancer progression. J. Thromb. Haemost.9(2), 237–249 (2011).
   PubMed Web of Science ®Google Scholar
• Konstantopoulos K , ThomasSN. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng.11, 177–202 (2009).
   PubMed Web of Science ®Google Scholar
• Varki A . Trousseau‘s syndrome: multiple definitions and multiple mechanisms. Blood110(6), 1723–1729 (2007).
   PubMed Web of Science ®Google Scholar
• Billroth T . Lectures on Surgical Pathology And Therapeutics: A Handbook For Students and Practictioners (8th Edition). The New Sydenham Society, London, UK (1878).
   Google Scholar
• Gasic GJ , GasicTB, StewartCC. Antimetastatic effects associated with platelet reduction. Proc. Natl Acad. Sci. USA61(1), 46–52 (1968).
   PubMed Web of Science ®Google Scholar
• Pinedo HM , VerheulHM, D‘AmatoRJ, FolkmanJ. Involvement of platelets in tumour angiogenesis? Lancet352(9142), 1775–1777 (1998).
   PubMed Web of Science ®Google Scholar
• Gay LJ , Felding-habermannB. Contribtion of platelets to tumour metastasis. Cancer.11(2), 123–134 (2011).
   Web of Science ®Google Scholar
• Modery-Pawlowski CL , MasterAM, PanV, HowardGP, Sen Gupta A. A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms. Biomacromolecules14(3), 910–919 (2013).
   PubMed Web of Science ®Google Scholar
• Labelle M , BegumS, HynesRO. Direct signaling between platelets and cancer cells induces an epithelial–mesenchymal-like transition and promotes metastasis. Cancer Cell20(5), 576–590 (2011).
   PubMed Web of Science ®Google Scholar
• Deryugina EI , QuigleyJP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev.25(1), 9–34 (2006).
   PubMed Web of Science ®Google Scholar
• Palumbo JS , TalmageKE, MassariJ V et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood105(1), 178–185 (2005).
   PubMed Web of Science ®Google Scholar
• Wirtz D , KonstantopoulosK, SearsonPC. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat. Rev. Cancer11(7), 512–522 (2011).
   PubMed Web of Science ®Google Scholar
• Amirkhosravi A , MousaSA, AmayaMet al. Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis. Methods Mol. Biol. 663, 241–259 (2010).
   PubMedGoogle Scholar
• Yu M , StottS, TonerM, MaheswaranS, HaberDA. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol.192(3), 373–382 (2011).
   PubMed Web of Science ®Google Scholar
• Schroeder A , HellerDA, WinslowMMet al. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer. 12(1), 39–50 (2012).
   Web of Science ®Google Scholar
• Huang Z , KingMR. An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation. Gene Ther.16(10), 1271–1282 (2009).
   PubMed Web of Science ®Google Scholar

Website

• Selexys Pharmaceuticals. www.selexys.com
   Google Scholar